SBIR/STTR programs will expire if Congress doesn’t reauthorize by September 30th. Senator Paul blocked reauthorization because of security problems. New provisions added to address security concerns.
Bill passed Senate, expected to pass House. SBIR/STTR programs extended for three more years.

President Biden established the National Biotechnology and Biomanufacturing Initiative to drive research and development to “Solve Our Greatest Challenges.” The Initiative’s goals strongly suggest more non-dilutive funding opportunities in grants for R&D as well as contracts related to bioproducts and biomanufacturing.

SBIR/STTR programs could expire Sept 30. Reauthorization opposed by Rand Paul and others. SBIR/STTR grants enable commercialization of federally funded research and have broad benefits that improve life for all Americans as well as billions around the globe.